US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Visby Medical
Visby Medical Receives FDA Clearance for the First At-Home PCR for Multiple Respiratory Viruses
July 02, 2026
From
Visby Medical
Via
Business Wire
Visby Medical and RAINN Launch Safe Access Program, Bringing Private, Lab-Accurate STI Testing to Sexual Assault Survivors
May 12, 2026
From
Visby Medical
Via
Business Wire
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
January 08, 2026
From
Visby Medical
Via
Business Wire
Tickers
LH
Visby Medical Tackles STI Epidemic with First At-Home FDA-Authorized PCR Test in Partnership with Google Cloud
November 12, 2025
From
Visby Medical
Via
Business Wire